Suppr超能文献

以咪唑并吡啶为导向基团的钌催化C(sp)-H键双烯丙基化反应

Ruthenium-Catalyzed C(sp)-H Bond Bisallylation with Imidazopyridines as Directing Groups.

作者信息

Liu Shuang, Jiang Hui, Liu Wannian, Zhu Xinju, Hao Xin-Qi, Song Mao-Ping

机构信息

College of Chemistry, Zhengzhou University, No. 100 of Science Road, Zhengzhou, Henan 450001, P. R. China.

出版信息

J Org Chem. 2020 Dec 4;85(23):15167-15182. doi: 10.1021/acs.joc.0c02029. Epub 2020 Nov 3.

Abstract

A Ru(II)-catalyzed bisallylation of imidazopyridines with vinylcyclopropanes or vinyl cyclic carbonate has been successfully realized. Notably, pharmacophore imidazopyridine was utilized as an intrinsic directing group, which gave access to value-added bisallylated products in high yields via double tandem C-H and C-C/C-O activation. The current methodology was featured with broad substrate scope, good functional group compatibility, and operational simplicity.

摘要

已成功实现了钌(II)催化的咪唑并吡啶与乙烯基环丙烷或碳酸乙烯酯的双烯丙基化反应。值得注意的是,药效团咪唑并吡啶被用作内在导向基团,通过双串联C-H和C-C/C-O活化以高产率获得了有价值的双烯丙基化产物。目前的方法具有底物范围广、官能团兼容性好和操作简单的特点。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验